Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...
A type of cardiovascular disease known to physicians as microvascular angina affects the heart’s tiniest arteries and causes chest pain. The disease is sneaky, in that it doesn’t show up on ...
SAN DIEGO, CA—Patients presenting with chest pain and a positive stress test but no sign of obstructive coronary disease pose a quandary for physicians and frustration for the patients themselves. Now ...
In patients with angina but no obstructive arteries on angiography, further testing with stress cardiac MRI improved diagnosing the cause of angina, resulting in better management and quality of life, ...
New research provides robust evidence that cardiac magnetic resonance (CMR) can noninvasively and accurately detect microvascular coronary obstruction in patients with angina. In the first of two ...
The Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition) was written by the members of the Basic Research Group, Atherosclerosis and Coronary Heart ...
Chest pain may still be angina even when the main heart arteries look clear. Using cardiac stress MRI (a heart scan that measures blood flow with magnetic resonance imaging), testing uncovered small ...
NEW ORLEANS — An evaluation of myocardial blood flow with stress perfusion cardiac magnetic resonance (CMR) imaging after a negative angiogram changed the presumed diagnosis and treatment in the ...
A new study following 250 British people experiencing angina-like chest pain found that half were given the all-clear when they actually had microvascular angina. Published in the Nature Medicine ...
Please provide your email address to receive an email when new articles are posted on . Sex-specific differences in the performance of noninvasive testing for ischemic heart disease necessitate a ...
Although the origin of cardiac syndrome X (CSX) is still debated, endothelial dysfunction leading to reduced coronary microvascular dilatory response and increased coronary resistance is thought to ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — In the first randomized trial of a therapy for treatment of patients with angina and nonobstructive ...